ArticleCureus2026
Trends in Survival and Short-Term Outcomes Among Preterm Infants Less Than 32 Weeks From 2016 to 2022: A Retrospective Cohort Study at a Tertiary Medical Center in the UAE.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Contemporary data on preterm infant outcomes are vital for improving healthcare resources and results, as well as guiding professionals and families in counselling and decision-making. Objective To examine the survival rates, in-hospital complications, and antenatal care practices for infants born before 32 weeks of gestational age. Methods Demographics and outcome data were retrospectively gathered, adhering to standard definitions, for a cohort of infants born before 32 weeks of gestational age admitted between January 2016 and December 2022 at Tawam Hospital, UAE. Results Of the 700 infants with gestational ages 22+0 to 31+6, over the seven years, 553 (79%) survived to discharge. Overall, the median (IQR) length of stay in survivors was 67 (42, 95) days. Bronchopulmonary dysplasia (BPD) (any grade) was 228 (40.5%), and 89 (12.9%) preterm infants had necrotizing enterocolitis (NEC) stage 2 and above. Late-onset sepsis was seen in 195 (30.1%) cases. Regarding neurological injury, intraventricular hemorrhage (IVH) grade 3 and above was recorded in 57 (9.2%) cases, and periventricular leukomalacia (PVL) was noted in 37 (8.4%) infants. Patent ductus arteriosus (PDA) treatment was given to 115 (16.7%), and retinopathy of prematurity (ROP) treatment was needed in 8.5% of preterm infants. The study was divided into two periods: period 1 (2016-2019) and period 2 (2020-2022). Mortality was 92 (23.8%) in period 1 vs. 55 (17.6%) in period 2. Morbidities between period 1 vs. period 2 were as follows: BPD 101 (33.8%) vs. 127 (48.1%) (p < 0.0001), PVL 13 (5.7%) vs. 24 (11.2%) (p < 0.038), and sepsis 90 (25.5%) vs. 105 (35.6%) (p = 0.005). Rates of ROP needing treatment and NEC≥2, 18 (7.1%) vs. 23 (10%) and 45 (11.8%) vs. 44 (14.3%), respectively, p=0.239 and p=0.327, respectively, and severe IVH 34 (10%) vs. 23 (8%) (p=0.357). Conclusion A significant increase in survival in less than 32 weeks was noted over the study period. Increase in survival was associated with a notable rise in BPD, PVL, and sepsis. Rates of ROP needing treatment and NEC ≥ 2 increased, but the rise didn't reach statistical significance. On the other hand, a non-statistically significant reduction in severe IVH cases was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.